Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study

World Journal of Gastroenterology

Volumn 9, Issue 10, 2003, Pages 2300-2307

  Lakatos, Laszlo ^a   Pandur, Tunde ^a   David, Gyula ^a   Balogh, Zsuzsanna ^b   Kuronya, Pal ^c   Tollas, Arpad ^d   Lakatos, Peter Laszlo ^e  

^a Csolnoky F Province Hospital   (Hungary)

^b Grof Eszterhazy Hospital   (Hungary)

^c Magyar Imre Hospital   (Hungary)

^d Municipal Hospital   (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTHRITIS; ARTHROPATHY; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CELIAC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; CULTURAL ANTHROPOLOGY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; ENTERITIS; EYE DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HUMAN; HUNGARY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT MONITORING; PHENOTYPE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE; SKIN DISEASE; SYMPTOMATOLOGY; SYSTEMIC DISEASE; THROMBOEMBOLISM; ULCERATIVE COLITIS;

EID: 0142151257     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i10.2300     Document Type: Article

References (47)

1. Podolsky DK. Inflammatory bowel disease. NEJM 2002; 347: 417-428
2. Farrell RL, Peppercorn MA. Ulcerative colitis. Lancet 2002; 359: 331-340
3. Lakatos L. Immunology of inflammatory bowel diseases. Acta Physiol Hung 2000; 87: 355-372
4. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998; 115: 182-205
5. Weiss A, Mayer L. Extraintestinal manifestations of inflammatory bowel disease. In: Allan RN, Rhodes JM, Hanauer SB, eds. Inflammatory Bowel Diseases. Churchill Livingstone, New York 1997: 623-636
6. Lamers CB. Treatment of extraintestinal complications of ulcerative colitis. Eur J Gastroenterol Hepatol 1997; 9: 850-853
7. Ljung T, Staun M, Grove O, Fausa O, Vatn MH, Hellstrom PM. Pyoderma gangrenosum associated with Crohn disease: Effect of TNF-alpha blockade with infliximab. Scand J Gastroenterol 2002; 37: 1108-1110
8. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine 1976; 55: 401-412
9. Orchard TR. Arthritis associated with inflammatory bowel disease. In: Bayless TM, Hanauer SB, eds. Advanced Therapy of Inflammatory Bowel Disease. Decker inc., Hamilton 2001; 279-282
10. Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes. Gastroenterology 2002; 123: 714-718
11. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997; 112: 1845-1853
12. D'Arienzo A, Manguso F, Scarpa R, Astarita C, D'Armiento FP, Bennato R, Gargano D, Sanges M, Mazzacca G. Ulcerative colitis, seronegative spondyloarthropathies and allergic diseases: The search for a link. Scand J Gastroenterol 2002; 37: 1156-1163
13. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history. Gut 1998; 42: 387-391
14. Russell AS. Arthritis, inflammatory bowel disease and histocompatibility antigens. Ann Int Med 1977; 86: 820-821
15. Lee YM, Kaplan MM. Management of primary sclerosing cholangitis. Am J Gastroenterol 2002; 97: 528-534
16. Heikius B, Niemela S, Lehtola J, Karttunen T, Lahde S. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease. Scand J Gastroenterol 1997; 32: 153-161
17. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. The National Cooperative Crohn's Disease Study: Extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77: 914-920
18. Rankin GB. Extraintestinal and systecim manifestations of inflammatory bowel disease. Med Clin North Am 1990; 74: 39-50
19. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Gastroenterology 1985; 88: 1818-1825
20. Monsen U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: An epidemiological study. Am J Gastroenterol 1990; 85: 711-716
21. Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002; 8: 158-161
22. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study. Am J Gastroenterol 2001; 96: 1116-1122
23. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996; 38: 738-741
24. Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Int Med 1988; 148: 297-302
25. Lee YM, Kaplan MM. Management of primary sclerosing cholangitis. Am J Gastroenterol 2002; 97: 528-534
26. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990; 74: 39-50
27. Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tysk C, Wallerstedt S. Prevalence of primery sclerosing cholangitis in patients with ulcerative cholitis. Gastroenterology 1991; 100: 1319-1323
28. Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ 3rd. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996; 110: 432-440
29. Perrett AD, Higgins G, Johnston HH, Massarella G, Truelove SC, Wrigth R. The liver in ulcerative colitis. Q J Med 1971; 40: 211-238
30. Perrett AD, Higgins G, Johnston HH, Massarella G, Truelove SC, Wrigth R. The liver in Crohn's disease. Q J Med 1971; 40: 187-209
31. Riegler G, D'Inca R, Sturniolo C, Corrao G, Blancho CDV, Di Leo V, Carratu R, Ingrosso M, Pelli MA, Morini S, Valpiani D, Cantarini D, Usai P, Papi C, Caprilli R. Hepatobiliary alterations in patients with inflammatory bowel disease: A multicenter study. Scand J Gastroenterol 1998; 33: 93-98
32. Broome U, Glaumann H, Hultcrantz R. Liver histology and follow-up of 68 patients with ulcerative colitis and normal liver function tests. Gut 1990; 31: 468-472
33. Mattila J, Aitola P, Matikainen M. Liver lesions found at colectomy in ulcerative colitis: Correlation between histological findings and biochemical parameters. J Clin Pathol 1994; 47: 1019-1021
34. Noussari HC, Provost TT, Anhalt GJ. Cutaneous manifestations of inflammatory bowel disease. In: Bayless TM, Hanauer SB, eds. Advanced Therapy of Inflammatory Bowel Disease. Decker inc, Hamilton 2001: 271-274
35. Tromm A, May D, Almus E, Voigt E, Greving I, Schwegler U, Griga T. Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol 2001; 39: 137-144
36. Giannadaki E, Potamianos S, Poussomoustakaki M, Kyriakou D, Fragkiadakis N, Manousos ON. Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitis. Am J Gastroenterol 1997; 92: 1872-1874
37. Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001; 121: 1080-1087
38. Lewis JD, Schwartz JS, Lichtenstein GR. Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma. Gastroenterology 2000; 118: 1018-1024
39. Guedon C, Le Cam-Duchez V, Lalaude O, Menard JF, Lerebours E, Borg JY. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 1448-1454
40. Meucci G, Pareti F, Vecchi M, Saibeni S, Bressi C, de Franchis R. Serum von Willebrand factor levels in patients with inflammatory bowel disease are related to systemic inflammation. Scand J Gastroenterol 1999; 34: 287-290
41. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106: 840-845
42. Liebman HA, Kashani N, Sutherland D, McGehee W, Kam AL. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 1998; 115: 830-834
43. Haslam N, Standen GR, Probert CS. An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11: 1289-1291
44. Grip O, Svensson PJ, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35: 619-623
45. Nagy Z, Nagy A, Karadi O, Figler M, Rumi G Jr, Suto G, Vincze A, Par A, Mozsik G. Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity. J Physiol Paris 2001; 95: 483-487
46. Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol 1998; 93: 504-514
47. Barthet M, Hastier P, Bernard JP, Bordes G, Frederick J, Allio S, Mambrini P, Saint-Paul MC, Delmont JP, Salducci J, Grimaud JC, Sahel J. Chronic pancreatitis and inflammatory bowel disease: True or coincidental association? Am J Gastroenterol 1999; 94: 2141-2148